Elusive sentinels at the Hodgkin checkpoint

Blood. 2020 Dec 17;136(25):2841-2842. doi: 10.1182/blood.2020009463.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Hodgkin Disease* / drug therapy
  • Humans
  • Programmed Cell Death 1 Receptor / therapeutic use
  • T-Lymphocytes
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents
  • Programmed Cell Death 1 Receptor